Titre : Virion

Virion : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet-Rich Plasma
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virion : Questions médicales les plus fréquentes", "headline": "Virion : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-12", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virion" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Structures virales", "url": "https://questionsmedicales.fr/mesh/D056224", "about": { "@type": "MedicalCondition", "name": "Structures virales", "code": { "@type": "MedicalCode", "code": "D056224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Nucléocapside", "alternateName": "Nucleocapsid", "url": "https://questionsmedicales.fr/mesh/D019251", "about": { "@type": "MedicalCondition", "name": "Nucléocapside", "code": { "@type": "MedicalCode", "code": "D019251", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Capside", "alternateName": "Capsid", "url": "https://questionsmedicales.fr/mesh/D002213", "about": { "@type": "MedicalCondition", "name": "Capside", "code": { "@type": "MedicalCode", "code": "D002213", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.500.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Enveloppe virale", "alternateName": "Viral Envelope", "url": "https://questionsmedicales.fr/mesh/D000086942", "about": { "@type": "MedicalCondition", "name": "Enveloppe virale", "code": { "@type": "MedicalCode", "code": "D000086942", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Virion", "alternateName": "Virion", "code": { "@type": "MedicalCode", "code": "D014771", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tibor Füzik", "url": "https://questionsmedicales.fr/author/Tibor%20F%C3%BCzik", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic." } }, { "@type": "Person", "name": "Pavel Plevka", "url": "https://questionsmedicales.fr/author/Pavel%20Plevka", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz." } }, { "@type": "Person", "name": "Liya Mukhamedova", "url": "https://questionsmedicales.fr/author/Liya%20Mukhamedova", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic." } }, { "@type": "Person", "name": "Antonín Přidal", "url": "https://questionsmedicales.fr/author/Anton%C3%ADn%20P%C5%99idal", "affiliation": { "@type": "Organization", "name": "Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic." } }, { "@type": "Person", "name": "Michael Way", "url": "https://questionsmedicales.fr/author/Michael%20Way", "affiliation": { "@type": "Organization", "name": "Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia - A GENFI study.", "datePublished": "2024-08-15", "url": "https://questionsmedicales.fr/article/39153518", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bbi.2024.08.030" } }, { "@type": "ScholarlyArticle", "name": "Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.", "datePublished": "2024-08-01", "url": "https://questionsmedicales.fr/article/39115847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.25593" } }, { "@type": "ScholarlyArticle", "name": "Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout.", "datePublished": "2024-07-30", "url": "https://questionsmedicales.fr/article/39140032", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2024.1424207" } }, { "@type": "ScholarlyArticle", "name": "Microstructure and coupling mechanisms in MnBi-FeSiB nanocomposites obtained by spark plasma sintering.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39043695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67353-7" } }, { "@type": "ScholarlyArticle", "name": "Saliva Versus Plasma Therapeutic Drug Monitoring of Valproic Acid in Jordanian Patients.", "datePublished": "2024-07-19", "url": "https://questionsmedicales.fr/article/39029516", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2357-8095" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Structures virales", "item": "https://questionsmedicales.fr/mesh/D056224" }, { "@type": "ListItem", "position": 3, "name": "Virion", "item": "https://questionsmedicales.fr/mesh/D014771" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virion - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virion", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virion", "description": "Comment identifier un virion dans un échantillon ?\nQuels tests sont utilisés pour détecter les virions ?\nLes virions peuvent-ils être visualisés au microscope ?\nQuelle est la méthode de culture des virions ?\nLes tests sérologiques détectent-ils les virions ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virion", "description": "Quels symptômes indiquent une infection virale ?\nLes virions causent-ils toujours des symptômes ?\nComment les symptômes varient-ils selon le virion ?\nLes symptômes d'une infection virale sont-ils immédiats ?\nLes virions peuvent-ils provoquer des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virion", "description": "Comment prévenir les infections virales ?\nLes masques protègent-ils contre les virions ?\nLes vaccins sont-ils efficaces contre tous les virions ?\nL'hygiène personnelle aide-t-elle à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virion", "description": "Quels traitements sont efficaces contre les virions ?\nLes antibiotiques sont-ils efficaces contre les virions ?\nComment les vaccins agissent-ils contre les virions ?\nLes traitements symptomatiques sont-ils utiles ?\nLes traitements antiviraux sont-ils toujours efficaces ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virion", "description": "Quelles complications peuvent survenir après une infection virale ?\nLes virions peuvent-ils causer des maladies chroniques ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le virion ?\nLes enfants sont-ils plus à risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virion", "description": "Quels sont les facteurs de risque d'infection virale ?\nLe stress affecte-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nL'environnement joue-t-il un rôle dans le risque viral ?\nLes habitudes alimentaires influencent-elles le risque viral ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Platelet-Rich+Plasma&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un virion dans un échantillon ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par microscopie électronique ou tests PCR." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les virions ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR, les cultures virales et les tests sérologiques sont courants." } }, { "@type": "Question", "name": "Les virions peuvent-ils être visualisés au microscope ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les virions peuvent être visualisés au microscope électronique." } }, { "@type": "Question", "name": "Quelle est la méthode de culture des virions ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les virions sont cultivés dans des cellules hôtes appropriées en laboratoire." } }, { "@type": "Question", "name": "Les tests sérologiques détectent-ils les virions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils détectent les anticorps contre les virions, pas les virions eux-mêmes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont fréquents." } }, { "@type": "Question", "name": "Les virions causent-ils toujours des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains virions peuvent être asymptomatiques chez l'hôte." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon le virion ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes dépendent du type de virus et de l'hôte infecté." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils immédiats ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, il peut y avoir une période d'incubation avant l'apparition des symptômes." } }, { "@type": "Question", "name": "Les virions peuvent-ils provoquer des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virions, comme ceux de la grippe, peuvent affecter le système nerveux." } }, { "@type": "Question", "name": "Comment prévenir les infections virales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Les masques protègent-ils contre les virions ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les masques réduisent la transmission des virions par voie respiratoire." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces contre tous les virions ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Non, chaque vaccin cible des virions spécifiques et ne protège pas contre tous." } }, { "@type": "Question", "name": "L'hygiène personnelle aide-t-elle à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle réduit le risque d'infections virales." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection virale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages peuvent exposer à de nouveaux virions et augmenter le risque d'infection." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre les virions ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux, comme l'oseltamivir, sont utilisés pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les virions ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Comment les vaccins agissent-ils contre les virions ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins stimulent le système immunitaire à reconnaître et combattre les virions." } }, { "@type": "Question", "name": "Les traitements symptomatiques sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à soulager les symptômes, mais ne traitent pas l'infection virale." } }, { "@type": "Question", "name": "Les traitements antiviraux sont-ils toujours efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité dépend du type de virus et de la résistance virale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une infection virale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la pneumonie, la déshydratation ou des infections secondaires peuvent survenir." } }, { "@type": "Question", "name": "Les virions peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virions, comme le VIH, peuvent entraîner des maladies chroniques." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont gérées par des traitements symptomatiques et des soins médicaux appropriés." } }, { "@type": "Question", "name": "Les complications varient-elles selon le virion ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virion peut entraîner des complications différentes selon l'hôte." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque de complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus vulnérables aux complications des infections virales." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection virale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le système immunitaire affaibli et l'exposition à des porteurs." } }, { "@type": "Question", "name": "Le stress affecte-t-il le risque d'infection virale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques peuvent affaiblir l'immunité et augmenter le risque d'infection virale." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle dans le risque viral ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque viral ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut affaiblir le système immunitaire et augmenter le risque." } } ] } ] }

Sources (10000 au total)

Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia - A GENFI study.

Inflammation has been proposed as a crucial player in neurodegeneration, including Frontotemporal Dementia (FTD). A few studies on sporadic FTD lead to inconclusive results, whereas large studies on g... Mesoscale technology was used to analyse levels of 30 inflammatory factors in 434 plasma samples, including 94 Symptomatic Mutation carriers [(SMC); 15 with mutations in Microtubule Associated Protein... The following cytokines were significantly upregulated (P<0.05) in MAPT and GRN SMC versus NC: Tumor Necrosis Factor (TNF)α, Interleukin (IL)-7, IL-15, IL-16, IL-17A. Moreover, only in GRN SMC, additi... We showed that inflammatory proteins are upregulated in MAPT and GRN SMC, with some specific factors altered in GRN only, whereas no changes were seen in C9ORF72 carriers. Notably, only IL-1α levels w...

Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.

Precise estimation of a patient's drug metabolism capacity is important for antiseizure dose personalization.... To quantify the differences in plasma concentrations for antiseizure drugs associated with variants of genes encoding drug metabolizing enzymes.... PubMed, Clinicaltrialsregister.eu, ClinicalTrials.gov, International Clinical Trials Registry Platform, and CENTRAL databases were screened for studies from January 1, 1990, to September 30, 2023, wit... Two reviewers performed independent study screening and assessed the following inclusion criteria: appropriate genotyping was performed, genotype-based categorization into subgroups was possible, and ... The Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines were followed for data extraction and subsequent quality, validity, and risk-of-bias assessments. The results from the inc... Plasma concentrations of antiseizure drugs were quantified with the dose-normalized area under the concentration-time curve, the dose-normalized steady state concentration, or the concentrations after... Data from 98 studies involving 12 543 adult participants treated with phenytoin, valproate, lamotrigine, or carbamazepine were analyzed. Studies were mainly conducted within East Asian (69 studies) or... This systematic review and meta-analysis found that CYP2C9 and CYP2C19 genotypes encoding low enzymatic capacity were associated with a clinically relevant increase in phenytoin plasma concentrations,...

Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout.

Prior research has highlighted the association between uric acid (UA) and the activation of the renin-angiotensin-aldosterone system (RAAS). However, the specific relationship between aldosterone, the... Our study involved 34534 hypertensive participants, assessing plasma aldosterone concentration (PAC)'s role in UA-related diseases, mainly hyperuricemia and gout. We applied multiple logistic regressi... Multivariate logistic regression analysis revealed a significant correlation between the occurrence of hyperuricemia and gout and the elevation of PAC levels. Compared to the first quartile (Q1) group... This study demonstrates a close association between elevated PAC levels and the development of UA-related diseases, namely hyperuricemia and gout, in hypertensive patients. Further prospective studies...

Gut microbiota, plasma metabolites, and osteoporosis: unraveling links via Mendelian randomization.

Osteoporosis, characterized by reduced bone density and heightened fracture risk, is influenced by genetic and environmental factors. This study investigates the interplay between gut microbiota, plas... Utilizing aggregated genome-wide association studies (GWAS) data, a comprehensive two-sample Mendelian Randomization (MR) analysis was performed involving 196 gut microbiota taxa, 1,400 plasma metabol... The MR analyses revealed ten gut microbiota taxa associated with osteoporosis, with five taxa positively linked to increased risk and five negatively associated. Additionally, 96 plasma metabolites ex... This study provides suggestive evidence of genetic correlations and causal links between gut microbiota, plasma metabolites, and osteoporosis. The findings underscore the complex, multifactorial natur...

Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes.

Genome-wide association studies (GWAS) have revealed numerous loci associated with multiple sclerosis (MS). However, the challenge lies in deciphering the mechanisms by which these loci influence the ... We systematically integrated MS GWAS data (N = 115,803) with human plasma proteome data (N = 7213) and conducted proteome-wide association studies (PWAS) to identify MS-associated pathogenic proteins.... The PWAS identified 25 statistically significant cis-regulated plasma proteins associated with MS at a false discovery rate of P < 0.05. Further analysis revealed that the abundance of 7 of these prot... Our proteomic analysis has identified PLEK, CR1, and CD59 as potential drug targets for MS treatment. Developing pharmacological inducers or inhibitors for these proteins could pave the way for new th...

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.

Genotyping and amyloid fibril detection in tissues are generally considered the diagnostic gold standard in transthyretin-related amyloidosis. Patients carry less stable TTR homotetramers prone to dis... We hypothesise that molecular sieving represents a promising method for isolating and concentrating trace TTR monomers from the tetramers present in plasma samples. Subsequently, immunodetection can b... The ImmunoSieve assay enable sensitive detection of monomeric transthyretin in plasma microsamples. Moreover, the circulating monomeric TTR levels were significantly higher in carriers of amyloidogeni... Monomeric TTR can function as a biomarker for evaluating disease progression and assessing responses to therapies targeted at stabilising native TTR....